Concepts (95)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Depression, Postpartum | 3 | 2016 | 10 | 1.490 |
Why?
|
| Research Personnel | 2 | 2015 | 6 | 1.010 |
Why?
|
| Depression | 3 | 2014 | 66 | 0.650 |
Why?
|
| Drug Monitoring | 3 | 2014 | 10 | 0.620 |
Why?
|
| Depressive Disorder, Major | 3 | 2013 | 26 | 0.610 |
Why?
|
| Antidepressive Agents | 2 | 2014 | 10 | 0.590 |
Why?
|
| Peripartum Period | 2 | 2014 | 2 | 0.580 |
Why?
|
| Hydrocortisone | 1 | 2016 | 6 | 0.550 |
Why?
|
| Stress, Psychological | 1 | 2016 | 39 | 0.530 |
Why?
|
| Education, Medical | 1 | 2015 | 13 | 0.510 |
Why?
|
| Biomedical Research | 1 | 2015 | 15 | 0.510 |
Why?
|
| Sertraline | 2 | 2013 | 7 | 0.510 |
Why?
|
| Benzodiazepines | 2 | 2013 | 7 | 0.510 |
Why?
|
| Physicians | 1 | 2015 | 22 | 0.500 |
Why?
|
| Postpartum Period | 1 | 2015 | 10 | 0.500 |
Why?
|
| Humans | 10 | 2016 | 3987 | 0.500 |
Why?
|
| Research Support as Topic | 1 | 2014 | 3 | 0.500 |
Why?
|
| Research | 1 | 2014 | 15 | 0.490 |
Why?
|
| Mood Disorders | 1 | 2014 | 6 | 0.480 |
Why?
|
| Mental Disorders | 1 | 2014 | 38 | 0.470 |
Why?
|
| Pregnancy Complications | 1 | 2014 | 13 | 0.470 |
Why?
|
| Body Weight | 1 | 2013 | 24 | 0.460 |
Why?
|
| Complementary Therapies | 1 | 2013 | 15 | 0.450 |
Why?
|
| Female | 7 | 2016 | 1951 | 0.440 |
Why?
|
| Pregnancy | 3 | 2016 | 121 | 0.350 |
Why?
|
| Adult | 4 | 2016 | 921 | 0.320 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2015 | 33 | 0.270 |
Why?
|
| United States | 2 | 2015 | 319 | 0.230 |
Why?
|
| Drug Therapy, Combination | 3 | 2013 | 38 | 0.190 |
Why?
|
| Treatment Outcome | 3 | 2013 | 286 | 0.170 |
Why?
|
| Psychotic Disorders | 1 | 2009 | 8 | 0.170 |
Why?
|
| Double-Blind Method | 2 | 2013 | 37 | 0.160 |
Why?
|
| Antipsychotic Agents | 2 | 2013 | 19 | 0.160 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 2 | 2013 | 12 | 0.150 |
Why?
|
| Risk Factors | 2 | 2015 | 304 | 0.140 |
Why?
|
| Saliva | 1 | 2016 | 5 | 0.140 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 132 | 0.130 |
Why?
|
| Societies, Scientific | 1 | 2015 | 1 | 0.130 |
Why?
|
| Certification | 1 | 2015 | 3 | 0.130 |
Why?
|
| Surveys and Questionnaires | 1 | 2016 | 144 | 0.130 |
Why?
|
| Young Adult | 1 | 2016 | 256 | 0.130 |
Why?
|
| Affect | 1 | 2015 | 10 | 0.130 |
Why?
|
| Suicidal Ideation | 1 | 2015 | 15 | 0.130 |
Why?
|
| Comorbidity | 1 | 2015 | 56 | 0.120 |
Why?
|
| Mass Screening | 1 | 2015 | 23 | 0.120 |
Why?
|
| Anxiety Disorders | 1 | 2015 | 22 | 0.120 |
Why?
|
| National Institute of Mental Health (U.S.) | 1 | 2014 | 1 | 0.120 |
Why?
|
| Psychiatry | 1 | 2014 | 4 | 0.120 |
Why?
|
| Adolescent | 1 | 2016 | 410 | 0.120 |
Why?
|
| Cohort Studies | 1 | 2015 | 135 | 0.120 |
Why?
|
| Carbamazepine | 1 | 2014 | 2 | 0.120 |
Why?
|
| Triazines | 1 | 2014 | 2 | 0.120 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2014 | 2 | 0.120 |
Why?
|
| Valproic Acid | 1 | 2014 | 5 | 0.120 |
Why?
|
| Mother-Child Relations | 1 | 2014 | 9 | 0.120 |
Why?
|
| Anxiety | 1 | 2014 | 22 | 0.120 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2014 | 13 | 0.120 |
Why?
|
| Male | 3 | 2013 | 1734 | 0.120 |
Why?
|
| Hallucinations | 1 | 2013 | 2 | 0.120 |
Why?
|
| Metabolism | 1 | 2013 | 3 | 0.120 |
Why?
|
| Memantine | 1 | 2013 | 4 | 0.120 |
Why?
|
| Folic Acid | 1 | 2013 | 1 | 0.120 |
Why?
|
| Acupuncture Therapy | 1 | 2013 | 1 | 0.120 |
Why?
|
| Hypericum | 1 | 2013 | 1 | 0.120 |
Why?
|
| Phototherapy | 1 | 2013 | 2 | 0.120 |
Why?
|
| S-Adenosylmethionine | 1 | 2013 | 3 | 0.120 |
Why?
|
| Massage | 1 | 2013 | 4 | 0.120 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2013 | 2 | 0.120 |
Why?
|
| Sex Factors | 1 | 2013 | 64 | 0.110 |
Why?
|
| Socioeconomic Factors | 1 | 2013 | 60 | 0.110 |
Why?
|
| Dietary Supplements | 1 | 2013 | 15 | 0.110 |
Why?
|
| Mothers | 1 | 2013 | 17 | 0.110 |
Why?
|
| Body Mass Index | 1 | 2013 | 54 | 0.110 |
Why?
|
| Age Factors | 1 | 2013 | 102 | 0.110 |
Why?
|
| Exercise | 1 | 2013 | 38 | 0.110 |
Why?
|
| Arylamine N-Acetyltransferase | 1 | 2001 | 1 | 0.100 |
Why?
|
| Fishes | 1 | 2001 | 1 | 0.100 |
Why?
|
| Pineal Gland | 1 | 2001 | 1 | 0.100 |
Why?
|
| Isoenzymes | 1 | 2001 | 8 | 0.100 |
Why?
|
| Multienzyme Complexes | 1 | 2001 | 7 | 0.100 |
Why?
|
| Cysteine Endopeptidases | 1 | 2001 | 12 | 0.100 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2001 | 18 | 0.100 |
Why?
|
| Aged | 1 | 2013 | 754 | 0.090 |
Why?
|
| Middle Aged | 1 | 2013 | 938 | 0.090 |
Why?
|
| Placebos | 1 | 2009 | 6 | 0.040 |
Why?
|
| Animals | 2 | 2014 | 1959 | 0.040 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2013 | 3 | 0.030 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2013 | 4 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2013 | 14 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 222 | 0.030 |
Why?
|
| Organ Culture Techniques | 1 | 2001 | 6 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 2001 | 13 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2001 | 18 | 0.020 |
Why?
|
| Light | 1 | 2001 | 22 | 0.020 |
Why?
|
| Circadian Rhythm | 1 | 2001 | 37 | 0.020 |
Why?
|